题名 | Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial |
作者 | |
发表日期 | 2020-05-15 |
发表期刊 | TRIALS 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Jiao-tai-wan Insomnia Traditional herbal medicine Randomized controlled trial Study protocol Pattern identification |
其他关键词 | MAGNETIC-RESONANCE SPECTROSCOPY ; PRACTICE PARAMETERS ; SLEEP ; ADENOSINE ; MEDICINE ; UPDATE ; BRAIN ; CARE ; GABA |
摘要 | Background Insomnia seriously affects people's normal lives and work. However, effective treatment strategies are scarce. The purpose of this study is to explore the efficacy and safety of Jiao-tai-wan (JTW) for ameliorating insomnia symptoms caused by disharmony of the heart and kidney. Design This is a randomized, double-blind, placebo-controlled pilot clinical trial. A total of 124 participants suffering from insomnia symptoms will be randomly assigned to the JTW or placebo group in an equal ratio. The participants will be asked to take JTW or placebo granules twice a day for 1 week. All data will be gathered at baseline and at the end of the drug intervention. The primary outcome measures will be the mean change in the Pittsburgh Sleep Quality Index (PSQI) from baseline to the end of the drug intervention. Secondary outcome measures will include the altered sleep parameters in polysomnography, H-1-magnetic resonance spectroscopy (H-1-MRS) evaluation, the Disharmony of Heart and Kidney Scoring System score, and blood tests, including the levels of serum adenosine and melatonin. A laboratory test will be taken before and after treatment to assess the safety of JTW. Discussion The outcomes of this study will confirm the efficacy of JTW for the treatment of insomnia symptoms and will also be used to monitor the safety of JTW. |
资助项目 | National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673733] |
出版者 | BMC |
出版地 | LONDON |
ISSN | 1745-6215 |
EISSN | 1745-6215 |
卷号 | 21期号:1页码:408 |
DOI | 10.1186/s13063-020-04299-x |
页数 | 9 |
WOS类目 | Medicine, Research & Experimental |
WOS研究方向 | Research & Experimental Medicine |
WOS记录号 | WOS:000536190400001 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 32414414 |
PMC记录号 | PMC7227231 |
SCOPUSEID | 2-s2.0-85084787812 |
通讯作者地址 | [Ye, Ren;Yuan, Zhengzhong]Wenzhou Med Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China. |
Scopus学科分类 | Medicine (miscellaneous);Pharmacology (medical) |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/7183 |
专题 | 附属第一医院_中医科 第二临床医学院、附属第二医院、育英儿童医院 附属第一医院_药学部药学部 |
通讯作者 | Ye, Ren; Yuan, Zhengzhong |
作者单位 | 1.Wenzhou Med Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; 2.Zhejiang Chinese Med Univ, Binwen Rd, Hangzhou 310053, Zhejiang, Peoples R China; 3.Wenzhou Med Univ, Dept Pharm, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; 4.Wenzhou Med Univ, 2nd Clin Coll, Chashan Higher Educ Pk, Wenzhou 325035, Zhejiang, Peoples R China; 5.Wenzhou Med Univ, Xray Dept, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; 6.Wenzhou Med Univ, Sleep Monitoring Ctr, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; 7.China Acad Chinese Med Sci, Res Inst, 16 Nanxiao St, Beijing 100700, Peoples R China |
第一作者单位 | 附属第一医院; 中医科 |
通讯作者单位 | 附属第一医院; 中医科 |
第一作者的第一单位 | 附属第一医院 |
推荐引用方式 GB/T 7714 | Zeng, Congcong,Liu, Xi,Hu, Lufeng,et al. Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial[J]. TRIALS,2020,21(1):408. |
APA | Zeng, Congcong., Liu, Xi., Hu, Lufeng., Feng, Yuan., Xia, Nengzhi., ... & Yuan, Zhengzhong. (2020). Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial. TRIALS, 21(1), 408. |
MLA | Zeng, Congcong,et al."Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial".TRIALS 21.1(2020):408. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论